Algorae Pharmaceuticals Ltd (1AI) — Long-term Investment Intensity
Algorae Pharmaceuticals Ltd (1AI) has a Long-term Investment Intensity of 1.2% as of June 2020. Long-term investments of AU$42.04K represent 1.2% of total assets of AU$3.39 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 1AI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Algorae Pharmaceuticals Ltd Long-term Investment Intensity (2014–2020)
This chart shows how Algorae Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2020. As of June 2020, the intensity stands at 1.2%, reflecting long-term investments of AU$42.04K against total assets of AU$3.39 Million AUD. For the complete balance sheet picture, see 1AI total asset value.
Annual Long-term Investment Intensity for Algorae Pharmaceuticals Ltd (2014–2020)
The table below presents the year-by-year Long-term Investment Intensity for Algorae Pharmaceuticals Ltd from 2014 to 2020, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 1AI liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 1.2% | AU$42.04K | AU$3.39 Million | ▼ -0.2 pp |
| 2019 | 1.5% | AU$85.17K | AU$5.76 Million | ▲ +0.9 pp |
| 2018 | 0.6% | AU$42.18K | AU$7.61 Million | ▼ -0.7 pp |
| 2015 | 1.2% | AU$67.36K | AU$5.46 Million | ▼ -46.2 pp |
| 2014 | 47.4% | AU$4.58 Million | AU$9.66 Million | — |